What we’re reading, November 21, 2016: 1 in 4 US children do not have access to essential healthcare, even though many are insured; the American Medical Association has released guidelines for the safe use of mobile health devices and applications; the FDA will delay finalization of its policy on the regulation of laboratory-developed tests.
Though the number of uninsured children in the United States has dropped to a record low 3.3 million, a recent report by the Children’s Health Fund has found that 1 in 4 children do not have access to essential healthcare. The study reported that even children with insurance can encounter barriers that prevent them from receiving primary care or specialty care, including financial obstacles and geographic barriers. According to the study, repealing the Affordable Care Act could exacerbate the problem by leaving over 3 million children suddenly uninsured.
The American Medical Association (AMA) has released guidelines on the safe and effective use of mobile health tools, which include mobile applications, fitness trackers, and other digital devices. The AMA recommends that digital tools should follow evidence-based best practices and support patient-centered care. It also said that physicians should receive legal counsel on patient privacy standards and educate patients on the possible privacy risks of some unregulated health apps.
The FDA had previously said that it would release its final guidelines on the regulation of laboratory-developed tests by the end of 2016, but a spokesperson recently announced that no final policy would be issued until the new administration of President-elect Donald J. Trump is in effect. Those in favor of applying medical device regulations to these unregulated tests have expressed concerns that the tests could produce inaccurate results and lead to unnecessary treatment.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More